Environment and social support for smoking cessation among community smokers in Beijing, China.

Authors:
Gu M; Li X; Qin T; Qiao K; Bai X and 4 more

Journal:
Tob Induc Dis

Publication Year: 2023

DOI:
10.18332/tid/172216

PMCID:
PMC10629225

PMID:
37941820

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Tob Induc Dis

Abbreviation: Tob Induc Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Substance Abuse

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
E-cigarettes on Instagram: Exploring vape content via an Australian vaping influencer.
Jancey J; Carey RN; Freeman B and 8 more (2024) - Transparency Score: 3/6
Electronic cigarette use and chest pain in US adults: Evidence from the PATH study.
Behrooz L; Xie W; Goghari A and 4 more (2024) - Transparency Score: 3/6
Electronic cigarette use in relation to changes in smoking status and respiratory symptoms.
Hedman L; Lyytinen G; Backman H and 7 more (2024) - Transparency Score: 3/6
Foods and beverages associated with smoking craving in heated tobacco product and cigarette smokers…
Miyoshi K; Kimura Y; Nakahata M and 1 more (2024) - Transparency Score: 3/6
National Smoking Cessation Services (NSCS) enrollment and their effect on long-term tobacco cessati…
Park J; Lim MK; Kim Y and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. The authors declare that they have no competing interests, financial or otherwise, related to the current work. All authors report that since the initial planning of the work, this research was supported by the National Key Research and Development Program of China and payments were made to their Institution."

Evidence found in paper:

"FUNDING This study was supported by the National Key Research and Development Program of China [2017YFC1309400]."

Evidence found in paper:

"TRIAL REGISTRATION The study was registered on the official website of the China Clinical Trial Registration Center. Identifier: ChiCTR1900024991"

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025